Results 251 to 260 of about 73,127 (334)

Circadian Clock Deregulation and Metabolic Reprogramming: A System Biology Approach to Tissue-Specific Redox Signaling and Disease Development. [PDF]

Int J Mol Sci
Konakchieva R, Mladenov M, Konaktchieva M, Sazdova I, Gagov H, Nikolaev G.   +5 more
europepmc   +1 more source

The Sleep Regularity Index: A New Way to Evaluate Shiftwork Schedules

Journal of Sleep Research, EarlyView.
ABSTRACT Sailors adhere to a variety of demanding shiftwork schedules (known as ‘watchbills’) which pose a challenge for sleep and wellbeing at sea. Previous research aimed at identifying viable watchbills based on how they protect sailors' sleep has largely relied on sleep duration. Findings have highlighted insufficient sleep during watchstanding but
Jacob R. Guzzetti, Panagiotis Matsangas, Siobhan Banks, Nita L. Shattuck   +3 more
wiley   +1 more source

Decoding the gut-sleep Nexus: a bibliometric mapping of gut microbiota and sleep disorders. [PDF]

Front Microbiol
Xu D, Lu Z, Li Q, Cheng Y, Yang Z.
europepmc   +1 more source

One Single Session to Sleep Them All? The Potential of Single‐Session Interventions for Insomnia

Journal of Sleep Research, EarlyView.
ABSTRACT Poor sleep and insomnia are pervasive public health concerns, with insomnia ranking as the second most prevalent mental health disorder in the general population. Moreover, insomnia is a significant predictor of subsequent depression and is frequently co‐occurring with other psychological difficulties.
Matteo Carpi, Erica Marie Szkody, Daniel Ruivo Marques   +2 more
wiley   +1 more source

The complexity and commonness of the two-process model of sleep regulation from a mathematical perspective. [PDF]

NPJ Biol Timing Sleep
Skeldon AC, Dijk DJ.
europepmc   +1 more source

The Effects of Daridorexant on Patients With Comorbid Insomnia Disorder and Untreated Mild Obstructive Sleep Apnoea: A Post Hoc Subgroup Analysis of a Phase 3, Randomised Clinical Trial

Journal of Sleep Research, EarlyView.
ABSTRACT Daridorexant, a dual orexin receptor antagonist, is approved for the treatment of insomnia disorder in adults. Approximately 30%–35% of patients with insomnia disorder also have obstructive sleep apnoea (OSA) of any severity. It is unclear whether sleep medications provide safe and effective treatment for insomnia in these patients.
Christopher J. Lettieri, Orestis Briasoulis, Damien Léger, Pierre‐Philippe Luyet, Jean‐Louis Pépin, Stuart F. Quan, Janna Raphelson, Paul Saskin, Atul Malhotra   +8 more
wiley   +1 more source

Variety of sleep and circadian rhythms of elderly dementia patients living in group home residences. [PDF]

Biogerontology
Kubota N, Matsuura N, Ebina M, Suzuki H, Miyagi N, Masukawa N, Kouga F, Yamanaka Y.   +7 more
europepmc   +1 more source

Is seasonal affective disorder a bipolar variant? [PDF]

, 2010
Postolache, Teodor T, Roecklein, Kathryn A, Rohan, Kelly J   +2 more
core  

Childhood OSAS and Obesity: Prospective Associations of Anthropometric Markers With Objective Sleep Outcomes in the CHAT Trial

Journal of Sleep Research, EarlyView.
ABSTRACT Obstructive sleep apnea syndrome (OSAS) is characterised by episodic upper airway obstruction that occurs during sleep and is common in children with obesity. The aim of the present study was to analyse the association between baseline anthropometric markers and objective sleep quality measures at follow‐up in school‐aged children with OSAS ...
Catalina Ramírez‐Contreras, Verónica Palma Elgueta, Lautaro Briones‐Suárez   +2 more
wiley   +1 more source

Role of late-night eating in circadian disruption and depression: a review of emotional health impacts. [PDF]

Phys Act Nutr
Kim YI, Kim E, Lee Y, Park J.
europepmc   +1 more source